| Screening (pre-treatment assessment) | Intervention phase | 6-month post-baseline (post-therapy) | 12-month post-baseline (follow-up) | 24-month post-baseline (follow-up) |
---|---|---|---|---|---|
 | Day 1–7 | Week 1–52 | Week 24 | Week 52 | Week 104 |
Informed consent | X | Â | Â | Â | Â |
Eligibility confirmation | X | Â | Â | Â | Â |
Randomisation | X | Â | Â | Â | Â |
Compulsory admission | Â | Â | Â | X | X |
CSQ | X | Â | X | X | Â |
QPR | X | Â | X | X | Â |
REQOL | X | Â | X | X | Â |
MHCS | X | Â | X | X | Â |
CSRI | X | Â | X | X | Â |
Intervention delivery | Â | X | Â | Â | Â |
Qualitative interview (intervention arm participants only) | Â | Â | Xa | Â | Â |